![](/img/cover-not-exists.png)
A phase II study of erlotinib monotherapy in pre-treated non-small cell lung cancer without EGFR gene mutation who have never/light smoking history: Re-evaluation of EGFR gene status (NEJ006/TCOG0903)
Matsumoto, Yoshifumi, Maemondo, Makoto, Ishii, Yoshiki, Okudera, Koichi, Demura, Yoshiki, Takamura, Kei, Kobayashi, Kunihiko, Morikawa, Naoto, Gemma, Akihiko, Ishimoto, Osamu, Usui, Kazuhiro, Harada,Volume:
86
Language:
english
Journal:
Lung Cancer
DOI:
10.1016/j.lungcan.2014.08.019
Date:
November, 2014
File:
PDF, 947 KB
english, 2014